Ophthalmology · Fountain Valley, CA
NPI
1316941966
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
11180 Warner Ave, Ste 151
Fountain Valley, CA, 92708
Phone (714) 444-0303
Groups this clinician bills Medicare through
Medicare paid, 2024
$414K
8,124 services
Medicare patients, 2024
698
Average age 76
Drug cost, 2024
$2.9M
4,559 prescriptions
Company payments, 2025
$1,991
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trung M Nguyen was code 92250 (angiography), 1,048 times for 666 patients. In total Trung M Nguyen billed 8,124 services in 25 codes, and Medicare paid $414K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92250 Angiography | Office | 1,048 | 666 | $31.32 | $33K |
| 92012 Ophthalmological E&M | Office | 988 | 505 | $76.59 | $76K |
| 92014 Ophthalmological E&M | Office | 914 | 569 | $105.29 | $96K |
| 92202 Ophthalmological E&M | Office | 747 | 501 | $12.82 | $9,574 |
| 92133 Computerized Ophthalmic Imaging | Office | 744 | 500 | $29.21 | $22K |
| 92132 Computerized Ophthalmic Imaging | Office | 741 | 500 | $24.82 | $18K |
| 92083 Vision, Hearing, and Speech Services | Office | 670 | 455 | $55.57 | $37K |
| 67820 Eye | Office | 618 | 371 | $14.83 | $9,166 |
| 92020 Ophthalmological E&M | Office | 531 | 528 | $22.91 | $12K |
| 65210 Eye | Office | 465 | 301 | $30.17 | $14K |
| 68761 Eye | Office | 389 | 62 | $94.18 | $37K |
| 92004 Ophthalmological E&M | Office | 116 | 116 | $119.08 | $14K |
| 92136 Ultrasound - Nonspecific | Office | 47 | 32 | $33.70 | $1,584 |
| 66984 Cataract Surgery | Facility | 47 | 30 | $433.67 | $20K |
| 66821 Cataract Surgery | Office | 21 | 16 | $292.87 | $6,150 |
By year: 2022 $462K for 9,131 services; 2023 $417K for 8,244 services; 2024 $414K for 8,124 services.
Medicare prescription drug claims, 2024
In 2024, the drug Trung M Nguyen prescribed most often to Medicare patients was Cequa (Cyclosporine), with 775 prescriptions and refills. In total Trung M Nguyen wrote 4,559 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cequa Cyclosporine | 775 | 1,172 | 174 | $662K |
| Restasis Cyclosporine | 590 | 980 | 148 | $598K |
| Xiidra Lifitegrast | 482 | 796 | 113 | $528K |
| Tyrvaya Varenicline Tartrate | 263 | 422 | 68 | $266K |
| Cyclosporine Generic | 255 | 525 | 80 | $144K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 239 | 355 | 44 | $126K |
| Lumigan Bimatoprost | 218 | 346 | 50 | $93K |
| Zerviate Cetirizine Hcl | 178 | 300 | 61 | $127K |
| Azelastine Hcl Generic | 149 | 303 | 47 | $4,768 |
| Vyzulta Latanoprostene Bunod | 147 | 229 | 34 | $62K |
| Prolensa Bromfenac Sodium | 145 | 180 | 60 | $59K |
| Latanoprost Generic | 143 | 258 | 40 | $1,817 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 105 | 205 | 28 | $2,541 |
| Prednisolone Acetate Generic | 102 | 107 | 54 | $4,017 |
| Bepreve Bepotastine Besilate | 65 | 84 | 22 | $25K |
Brand drugs: 3,850 claims; generic drugs: 709 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trung M Nguyen $1,991 ($1,991 in general payments such as food, travel and fees) from 11 companies. The largest payer was Alcon Vision LLC with $577.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 10 | $577 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 8 | $295 |
| Harrow Eye, LLC | 6 | $287 |
| Abbvie Inc. ABBV | 2 | $175 |
| Amgen Inc. AMGN | 2 | $168 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $143 |
| Gilead Sciences, Inc. GILD | 1 | $120 |
| Oyster Point Pharma, Inc. | 3 | $89.05 |
| Bausch & Lomb Americas Inc. BLCO | 4 | $79.21 |
| Rayner Intraocular Lenses Limited | 1 | $36.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.